Literature DB >> 21871172

The role of peroxidases in the pathogenesis of atherosclerosis.

Jong-Gil Park1, Goo Taeg Oh.   

Abstract

Reactive oxygen species (ROS), which include superoxide anions and peroxides, induce oxidative stress, contributing to the initiation and progression of cardiovascular diseases involving atherosclerosis. The endogenous and exogenous factors hypercholesterolemia, hyperglycemia, hypertension, and shear stress induce various enzyme systems such as nicotinamide adenine dinucleotide (phosphate) oxidase, xanthine oxidase, and lipoxygenase in vascular and immune cells, which generate ROS. Besides inducing oxidative stress, ROS mediate signaling pathways involved in monocyte adhesion and infiltration, platelet activation, and smooth muscle cell migration. A number of antioxidant enzymes (e.g., superoxide dismutases, catalase, glutathione peroxidases, and peroxiredoxins) regulate ROS in vascular and immune cells. Atherosclerosis results from a local imbalance between ROS production and these antioxidant enzymes. In this review, we will discuss 1) oxidative stress and atherosclerosis, 2) ROS-dependent atherogenic signaling in endothelial cells, macrophages, and vascular smooth muscle cells, 3) roles of peroxidases in atherosclerosis, and 4) antioxidant drugs and therapeutic perspectives.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21871172     DOI: 10.5483/bmbrep.2011.44.8.497

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  31 in total

1.  Novel links among peroxiredoxins, endothelial dysfunction, and severity of atherosclerosis in type 2 diabetic patients with peripheral atherosclerotic disease.

Authors:  Eman El Eter; Abeer Al Masri; Shahid Habib; Hana Al Zamil; Ahmed Al Hersi; Fawaz Al Hussein; Mohamed Al Omran
Journal:  Cell Stress Chaperones       Date:  2013-06-26       Impact factor: 3.667

2.  Initial reduction of oxidative stress by angiotensin receptor blocker contributes long term outcomes after percutaneous coronary intervention.

Authors:  Tadanori Noro; Naofumi Takehara; Kazuhiro Sumitomo; Toshiharu Takeuchi; Yoshinao Ishii; Jun-Ichi Kato; Jun-Ichi Kawabe; Naoyuki Hasebe
Journal:  Am J Cardiovasc Dis       Date:  2014-12-29

3.  Myeloid deletion of nuclear factor erythroid 2-related factor 2 increases atherosclerosis and liver injury.

Authors:  Alan R Collins; Anisha A Gupte; Ruirui Ji; Maricela R Ramirez; Laurie J Minze; Joey Z Liu; Magda Arredondo; Yuelan Ren; Tuo Deng; Jun Wang; Christopher J Lyon; Willa A Hsueh
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09-27       Impact factor: 8.311

4.  MCPIP is induced by cholesterol and participated in cholesterol-caused DNA damage in HUVEC.

Authors:  Jingjing Da; Ming Zhuo; Minzhang Qian
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  Insights into the antiatherogenic molecular mechanisms of andrographolide against Porphyromonas gingivalis-induced atherosclerosis in rabbits.

Authors:  Rami Al Batran; Fouad Al-Bayaty; Mazen M Jamil Al-Obaidi; Amer Ashrafi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-08-30       Impact factor: 3.000

6.  Metformin reduces the expression of NADPH oxidase and increases the expression of antioxidative enzymes in human monocytes/macrophages cultured in vitro.

Authors:  Łukasz Bułdak; Krzysztof Łabuzek; Rafał Jakub Bułdak; Grzegorz Machnik; Aleksandra Bołdys; Marcin Basiak; Okopień Bogusław
Journal:  Exp Ther Med       Date:  2016-01-11       Impact factor: 2.447

7.  KR-31543 reduces the production of proinflammatory molecules in human endothelial cells and monocytes and attenuates atherosclerosis in mouse model.

Authors:  Jae-Hoon Choi; Ji-Young Yoo; Sun-Ok Kim; Sung-Eun Yoo; Goo Taeg Oh
Journal:  Exp Mol Med       Date:  2012-12-31       Impact factor: 8.718

8.  The influence of Nrf2 on cardiac responses to environmental stressors.

Authors:  Reuben Howden; Eva Gougian; Marcus Lawrence; Samantha Cividanes; Wesley Gladwell; Laura Miller-DeGraff; Page H Myers; D Clay Rouse; Robert B Devlin; Hye-Youn Cho; Steven R Kleeberger
Journal:  Oxid Med Cell Longev       Date:  2013-04-22       Impact factor: 6.543

Review 9.  Translocator protein (18 kDa): a promising therapeutic target and diagnostic tool for cardiovascular diseases.

Authors:  Xiaolong Qi; Jiahong Xu; Fei Wang; Junjie Xiao
Journal:  Oxid Med Cell Longev       Date:  2012-11-28       Impact factor: 6.543

Review 10.  Nrf2 and cardiovascular defense.

Authors:  Reuben Howden
Journal:  Oxid Med Cell Longev       Date:  2013-04-04       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.